According to the Zhitong Finance App, Kangzhe Pharmaceutical (00867.HK) announced its 2026 interim results. The turnover increased 12.5% year on year to about 4.5 billion yuan, gross profit increased 11.4% year on year to about 3.21 billion yuan, profit during the period increased 4.3% year on year to 971.5 million yuan, profit attributable to company owners increased 4.77% year on year to 986 million yuan, basic profit per share, and an interim dividend of 0.1634 yuan per share.

According to the Zhitong Finance App, Kangzhe Pharmaceutical (00867.HK) announced its 2026 interim results. The turnover increased 12.5% year on year to about 4.5 billion yuan, gross profit increased 11.4% year on year to about 3.21 billion yuan, profit during the period increased 4.3% year on year to 971.5 million yuan, profit attributable to company owners increased 4.77% year on year to 986 million yuan, basic profit per share, and an interim dividend of 0.1634 yuan per share.